DC
GILD icon

Diametric Capital’s Gilead Sciences GILD Stock Holding History

Diametric Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,240
Closed -$272K – 373
2024
Q3 		$272K Buy
+3,240
New +$247K 0.13% 231
2019
Q3 		– Sell
-30,315
Closed -$2.05M – 114
2019
Q2 		$2.05M Buy
+30,315
New +$1.99M 1.3% 26
2019
Q1 		– Sell
-48,511
Closed -$3.03M – 112
2018
Q4 		$3.03M Buy
48,511
+880
+2% +$61.5K 2.34% 7
2018
Q3 		$3.68M Buy
+47,631
New +$3.6M 3.2% 2

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Diametric Capital's GILD Position: Q4 2024 in Review

Diametric Capital sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 3,240 shares — an estimated $272K sold.

Diametric Capital first reported a position in GILD in Q3 2018 and held it in 4 quarters. The position peaked at $3.68M in Q3 2018. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Diametric Capital reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Diametric Capital sold 3,240 Gilead Sciences shares in Q4 2024, an estimated $272K.
  • Diametric Capital first reported a position in Gilead Sciences in Q3 2018 and held it in 4 quarters.
  • Diametric Capital's Gilead Sciences position peaked at $3.68M in Q3 2018.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Diametric Capital's 13F filing for Q4 2024, filed 12 Feb 2025.